​

Organon (OGN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

OGN Stock Forecast

Organon (OGN) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $14.00, with a high of $18.00 and a low of $10.00. This represents a 39.03% increase from the last price of $10.07.

$10 $13 $16 $19 $22 $25 High: $18 Avg: $14 Low: $10 Last Closed Price: $10.07

OGN Stock Rating

Organon stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (66.67%), 1 Hold (16.67%), 1 Sell (16.67%), and 0 Strong Sell (0.00%).

Buy
Total 6 1 1 4 0 Strong Sell Sell Hold Buy Strong Buy

OGN Price Target Upside V Benchmarks

TypeNameUpside
StockOrganon39.03%
SectorHealthcare Stocks 24.81%
IndustryDrug Manufacturers - General Stocks22.02%

Price Target Trends

1M3M12M
# Anlaysts122
Avg Price Target$18.00$14.00$14.00
Last Closing Price$10.07$10.07$10.07
Upside/Downside78.75%39.03%39.03%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 252-3-27
May, 25212-27
Apr, 25213-28
Mar, 25313-29
Feb, 25313-29
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 15, 2025David AmsellemPiper Sandler$18.00$8.77105.25%78.75%
May 05, 2025Terence FlynnMorgan Stanley$10.00$8.7214.68%-0.70%
Apr 29, 2024David AmsellemPiper Sandler$24.00$18.8527.32%138.33%
Jun 26, 2023David AmsellemPiper Sandler$34.00$20.3766.91%237.64%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 15, 2025Piper SandlerOverweightOverweighthold
Dec 17, 2024Goldman SachsNeutralNeutralhold
Apr 29, 2024Piper SandlerOverweightOverweighthold
Mar 13, 2024Piper SandlerOverweightOverweighthold
Jan 12, 2024Piper SandlerOverweightOverweighthold
Dec 12, 2023Piper SandlerOverweightOverweighthold
Nov 09, 2023Piper SandlerOverweightOverweighthold
Jun 08, 2023Morgan StanleyEqual-WeightEqual-Weighthold
May 09, 2023Morgan StanleyEqual-WeightEqual-Weighthold
Sep 06, 2022Piper SandlerOverweightupgrade

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.33$3.61$4.01$3.36----
Avg Forecast$6.28$4.98$4.07$4.11$4.10$4.34$4.49$4.55
High Forecast$6.38$5.16$4.37$4.18$4.42$4.55$4.70$4.77
Low Forecast$6.19$4.85$3.97$4.06$3.63$4.19$4.34$4.40
Surprise %-15.13%-27.51%-1.47%-18.25%----

Revenue Forecast

$6B $6B $6B $6B $7B $7B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.30B$6.17B$6.26B$6.40B----
Avg Forecast$6.27B$6.18B$6.21B$6.41B$6.43B$6.52B$6.46B$6.50B
High Forecast$6.35B$6.35B$6.26B$6.42B$6.50B$6.52B$6.70B$6.75B
Low Forecast$6.20B$6.06B$6.18B$6.40B$6.34B$6.52B$6.29B$6.34B
Surprise %0.47%-0.17%0.79%-0.06%----

Net Income Forecast

$750M $930M $1B $1B $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.35B$917.00M$1.02B$864.00M----
Avg Forecast$1.61B$969.57M$1.02B$1.06B$1.03B$1.12B$1.15B$1.17B
High Forecast$1.63B$1.16B$1.23B$1.07B$1.13B$1.17B$1.21B$1.22B
Low Forecast$1.59B$775.66M$818.40M$1.04B$930.46M$1.07B$1.11B$1.13B
Surprise %-16.08%-5.42%--18.15%----

OGN Forecast FAQ

Is Organon stock a buy?

Organon stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Organon is a favorable investment for most analysts.

What is Organon's price target?

Organon's price target, set by 6 Wall Street analysts, averages $14 over the next 12 months. The price target range spans from $10 at the low end to $18 at the high end, suggesting a potential 39.03% change from the previous closing price of $10.07.

How does Organon stock forecast compare to its benchmarks?

Organon's stock forecast shows a 39.03% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the drug manufacturers - general stocks industry (22.02%).

What is the breakdown of analyst ratings for Organon over the past three months?

  • June 2025: 28.57% Strong Buy, 0% Buy, 42.86% Hold, 0% Sell, 28.57% Strong Sell.
  • May 2025: 28.57% Strong Buy, 14.29% Buy, 28.57% Hold, 0% Sell, 28.57% Strong Sell.
  • April 2025: 25.00% Strong Buy, 12.50% Buy, 37.50% Hold, 0% Sell, 25.00% Strong Sell.

What is Organon’s EPS forecast?

Organon's average annual EPS forecast for its fiscal year ending in December 2025 is $4.1, marking a 22.02% increase from the reported $3.36 in 2024. Estimates for the following years are $4.34 in 2026, $4.49 in 2027, and $4.55 in 2028.

What is Organon’s revenue forecast?

Organon's average annual revenue forecast for its fiscal year ending in December 2025 is $6.43B, reflecting a 0.41% increase from the reported $6.4B in 2024. The forecast for 2026 is $6.52B, followed by $6.46B for 2027, and $6.5B for 2028.

What is Organon’s net income forecast?

Organon's net income forecast for the fiscal year ending in December 2025 stands at $1.03B, representing an 19.37% increase from the reported $864M in 2024. Projections indicate $1.12B in 2026, $1.15B in 2027, and $1.17B in 2028.